Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
ClinLife is a patient-facing clinical trial discovery and application platform. Its core goal is to connect patients with suitable clinical studies. The page states that 1.6 million people have used the platform to find relevant studies and emphasizes that it is free for patients to use.
The platform’s process is relatively clear: patients first complete a short questionnaire for initial matching, then choose a certified research center, such as a university hospital, after which a study doctor contacts them. During the study, patients receive ongoing care from doctors and can stop participating at any time. ClinLife also supports email alert subscriptions: after entering an email address, address, and postal code, users can receive notifications when new studies related to their diagnosis become available within approximately 100 km.
The page clearly states that ClinLife is free for patients, but it does not disclose its pricing model for research institutions, hospitals, pharmaceutical companies, or CROs. It also does not specify whether there are premium plans, sponsored listings, recruitment service fees, or other monetization methods. Therefore, from a SaaS evaluation perspective, pricing transparency is limited.
The advantages are its low barrier to entry for patients, simple process, and emphasis on data security and privacy. The certified research center and doctor contact mechanism also helps build trust. The drawbacks are that publicly available information is limited: it does not disclose key enterprise software capabilities such as third-party integrations, APIs, backend permissions, team collaboration, or data compliance certifications. It also does not show the specific size of its study database, country coverage, or disease scope.
ClinLife is better suited for patients who want to proactively search for clinical trial opportunities, especially those who want to receive study notifications based on their diagnosis and geographic location. For research institutions or pharmaceutical recruitment teams, the available text is insufficient to determine whether it offers full enterprise-grade patient recruitment management capabilities.
Based on the provided text, it is not possible to determine whether clinlife.pe is accessible in mainland China, so its status is currently rated as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on clinlife.pe official site.
clinlife.pe is an Peru Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach clinlife.pe directly.